EARLY Act Reauthorization of 2025
Breast Cancer Education for Young Women: Program Extension
The EARLY Act Reauthorization of 2025 is currently being reviewed by the House Committee on Energy and Commerce. It recently moved out of a subcommittee and is waiting for the full committee to consider it. The bill is actively moving through the early stages of the legislative process.
Legislative Progress
This bill has support from both parties and extends a long-standing health program. It is likely to pass because it is not controversial and helps with early cancer detection.
Key Points
- This bill extends a federal program that teaches young women about breast health and the risks of breast cancer. It moves the end date of the program from 2026 to 2031.
- The program focuses on reaching women under age 45 and those at higher risk for breast cancer. It helps them understand their bodies and when to talk to a doctor about changes.
- By keeping this law active, the government can continue to fund public health campaigns and research. These efforts aim to find breast cancer earlier when it is easier to treat.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Committee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Subcommittee Consideration and Mark-up Session Held
Referred to the Subcommittee on Health.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
EARLY Act Reauthorization of 2025
Data Sources
Sponsor
Cosponsors
(17)Analysis generated by AI. Always verify with official sources.